LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Home・Listă Acțiuni・Compugen Ltd

Compugen Ltd

Deschisă

1.91 -3.05

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

1.91

Maxim

1.97

Indicatori cheie
By Trading Economics
Venit	2.6M -7.3M
Vânzări	-31M 2.6M
EPS	-0.08
Marjă de profit	-283.978
EBITDA	-8.5M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+103.05 upside

Dividende
By Dow Jones
Următoarele câștiguri	5 nov. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	47M 640M
Deschiderea anterioară	4.96
Închiderea anterioară	1.91

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

1.96 / 2.01 Suport & Rezistență

Compugen Ltd Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

19 dec. 2023, 12:14 UTC

Achiziții, Fuziuni, Preluări

Compugen Stock Rockets On Anti-Tumor Drug Deal With Gilead -- MarketWatch

Comparație

Modificare preț

Compugen Ltd Așteptări

Obiectiv de preț

By TipRanks

103.05% sus

Prognoză pe 12 luni

Medie 4 USD 103.05%

Maxim 4 USD

Minim 4 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCompugen Ltd - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

3 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 3 analiști care au acordat evaluări ale acțiunilor Compugen Ltd - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

1.96 / 2.01Suport & Rezistență

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Bullish events outweigh bearish events.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

Despre Compugen Ltd

Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.